JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/26448

Title: Synthesis of 213Bi-DOTATOC for peptide receptor alpha-therapy of GEP-NET patients refractory to beta therapy
Authors: MORGENSTERN Alfred
BRUCHERTSEIFER Frank
APOSTOLIDIS Christos
GIESEL Frederik
MIER Walter
HABERKORN Uwe
KRATOCHWIL Clemens
Citation: JOURNAL OF NUCLEAR MEDICINE vol. 53 (Supplement 1) p. 455
Publisher: SOC NUCLEAR MEDICINE INC
Publication Year: 2012
JRC Publication N°: JRC72901
ISSN: 0161-5505
URI: http://jnumedmtg.snmjournals.org/cgi/content/meeting_abstract/53/1_MeetingAbstracts/455
http://publications.jrc.ec.europa.eu/repository/handle/111111111/26448
Type: Contributions to Conferences
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top